The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: A population-based analysis of 9208 consecutive cases

BJU International

Volumn 101, Issue 7, 2008, Pages 826-832

  Walz, Jochen ^a,b   Montorsi, Francesco ^c   Jeldres, Claudio ^a   Suardi, Nazareno ^a,c   Shariat, Shahrokh F ^d   Perrotte, Paul ^a   Arjane, Philippe ^a   Graefen, Markus ^b   Pharand, Daniel ^a   Karakiewicz, Pierre I ^a,e  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Martini Clinic Prostate Cancer Center   (Germany)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Age; Comorbidity; Nomogram; Perioperative mortality; Prostate cancer; Surgical volume

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BOOTSTRAPPING; COMORBIDITY; CONTROLLED STUDY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOMOGRAM; POPULATION BASED CASE CONTROL STUDY; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROBABILITY; PROSTATECTOMY; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL RISK;

AGED; AGED, 80 AND OVER; COMORBIDITY; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUEBEC; SURGERY;

EID: 40449101382     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07373.x     Document Type: Article

References (23)

1. Alibhai SM, Leach M, Tomlinson G et al. 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity. J Natl Cancer Inst 2005 97 : 1525 32
2. Konety BR, Allareddy V, Modak S, Smith B. Mortality after major surgery for urologic cancers in specialized urology hospitals: are they any better? J Clin Oncol 2006 24 : 2006 12
3. Karakiewicz PI, Bazinet M, Aprikian AG, Tanguay S, Elhilali MM. Thirty-day mortality rates and cumulative survival after radical retropubic prostatectomy. Urology 1998 52 : 1041 6
4. Hall WH, Jani AB, Ryu JK, Narayan S, Vijayakumar S. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer. Prostate Cancer Prostatic Dis 2005 8 : 22 30
5. Bianco FJ Jr, Riedel ER, Begg CB, Kattan MW, Scardino PT. Variations among high Volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters. J Urol 2005 173 : 2099 103
6. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996 15 : 361 87
7. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001 28 : 555 65
8. Ellison LM, Heaney JA, Birkmeyer JD. The effect of hospital Volume on mortality and resource use after radical prostatectomy. J Urol 2000 163 : 867 9
9. Mazumdar M, Glassman JR. Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments. Stat Med 2000 19 : 113 32
10. Begg CB, Riedel ER, Bach PB et al. Variations in morbidity after radical prostatectomy. N Engl J Med 2002 346 : 1138 44
11. Lu-Yao GL, Albertsen P, Warren J, Yao SL. Effect of age and surgical approach on complications and short-term mortality after radical prostatectomy - a population-based study. Urology 1999 54 : 301 7
12. Goldenberg SL, Ramsey EW, Jewett MA. Prostate cancer: 6. Surgical treatment of localized disease. CMAJ 1998 159 : 1265 71
13. Fowler FJ Jr, McNaughton Collins M, Albertsen PC, Zietman A, Elliott DB, Barry MJ. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 2000 283 : 3217 22
14. Yan Y, Carvalhal GF, Catalona WJ, Young JD. Primary treatment choices for men with clinically localized prostate carcinoma detected by screening. Cancer 2000 88 : 1122 30
15. Bubolz T, Wasson JH, Lu-Yao G, Barry MJ. Treatments for prostate cancer in older men: 1984-97. Urology 2001 58 : 977 82
16. Alibhai SM, Naglie G, Nam R, Trachtenberg J, Krahn MD. Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol 2003 21 : 3318 27
17. Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS. Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol 2003 21 : 401 5
18. Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med 2002 137 : 511 20
19. Kattan MW, Potters L, Blasko JC et al. Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. Urology 2001 58 : 393 9
20. Steuber T, Graefen M, Haese A et al. Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy. J Urol 2006 175 : 939 44
21. Specht MC, Kattan MW, Gonen M, Fey J, Van Zee KJ. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 2005 12 : 654 9
22. Steyerberg EW, Bleeker SE, Moll HA, Grobbee DE, Moons KG. Internal and external validation of predictive models: a simulation study of bias and precision in small samples. J Clin Epidemiol 2003 56 : 441 7
23. Cagiannos I, Karakiewicz P, Eastham JA et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 2003 170 : 1798 803